A new research collaboration between Insight Genetics and Vanderbilt-Ingram Cancer Center includes an exclusive licensing agreement to commercialize a new genetic test to improve treatment selection for breast cancer patients with poor prognosis.
Read MoreFDA has accepted a supplemental new drug application from Navidea Biopharmaceuticals, granting priority review for the expanded use of injection with Lymphoseek, as indicated for sentinel lymph node detection in patients with head and neck cancer.
Read MoreAn analysis of past clinical trials in the development of advanced therapies for non-small cell lung cancer suggests that success can be improved if identified biomarkers or receptors are used as the targets of the drug.
Read MoreResearchers at the National Cancer Institute have launched a trial to determine whether assigning treatment based on specific gene mutations can provide benefit to patients with metastatic solid tumors.
Read More
New products include the Cytation 3 cell imaging multi-mode reader by BioTek and the myPlan Lung Cancer test from Myriad.
Read More